Sign up to save your podcasts
Or
Share HNSCC: Current and Emerging Therapeutic Strategies
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
HNSCC: Current and Emerging Therapeutic Strategies
In this episode, Aarti Bhatia, MD, MPH, and Deborah J. Wong, MD, PhD, discuss the rapidly evolving treatment landscape for recurrent, metastatic, and locally advanced head and neck squamous cell carcinoma (HNSCC), including the growing role of immune checkpoint inhibitors, perioperative treatment strategies, EGFR-targeted bispecific antibodies, antibody–drug conjugates, HPV-targeted vaccines, and novel radiosensitizers. The discussion also explores emerging phase III clinical trials, treatment sequencing considerations, and future precision oncology approaches for HPV-positive and HPV-negative patients with head and neck cancer.
Presenters:
Aarti Bhatia, MD, MPH
Associate Professor of Medicine (Medical Oncology)
Clinical Research Team Leader, Head and Neck Cancers Program
Yale Cancer Center
New Haven, Connecticut
Deborah J. Wong, MD, PhD
Director, Head and Neck Medical Oncology Program
Associate Clinical Professor of Medicine
Division of Hematology/Oncology
University of California, Los Angeles (UCLA)
Los Angeles, California
Link to full program:
https://bit.ly/49kViqg
Get access to all of our new podcasts by subscribing to the Decera Clinical Education Oncology Podcast on Apple Podcasts, YouTube Music, or Spotify.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
View all episodes
By Decera Clinical Education
4.9
1010 ratings
In this episode, Aarti Bhatia, MD, MPH, and Deborah J. Wong, MD, PhD, discuss the rapidly evolving treatment landscape for recurrent, metastatic, and locally advanced head and neck squamous cell carcinoma (HNSCC), including the growing role of immune checkpoint inhibitors, perioperative treatment strategies, EGFR-targeted bispecific antibodies, antibody–drug conjugates, HPV-targeted vaccines, and novel radiosensitizers. The discussion also explores emerging phase III clinical trials, treatment sequencing considerations, and future precision oncology approaches for HPV-positive and HPV-negative patients with head and neck cancer.
Presenters:
Aarti Bhatia, MD, MPH
Associate Professor of Medicine (Medical Oncology)
Clinical Research Team Leader, Head and Neck Cancers Program
Yale Cancer Center
New Haven, Connecticut
Deborah J. Wong, MD, PhD
Director, Head and Neck Medical Oncology Program
Associate Clinical Professor of Medicine
Division of Hematology/Oncology
University of California, Los Angeles (UCLA)
Los Angeles, California
Link to full program:
https://bit.ly/49kViqg
Get access to all of our new podcasts by subscribing to the Decera Clinical Education Oncology Podcast on Apple Podcasts, YouTube Music, or Spotify.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
More shows like Decera Clinical Education Oncology Podcast
View all
Stuff You Should Know
78,636 Listeners
Criminal
37,636 Listeners
Hidden Brain
43,528 Listeners
NEJM This Week
319 Listeners
JAMA Clinical Reviews
506 Listeners
ASCO Daily News
57 Listeners
The Curbsiders Internal Medicine Podcast
3,360 Listeners
The Daily
111,948 Listeners
ASCO Guidelines
47 Listeners
Blood Podcast
51 Listeners
Oncology Today with Dr Neil Love
59 Listeners
BioCentury This Week
34 Listeners
Two Onc Docs
195 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
46 Listeners